World's Best Scientists 2026 revealed!

Overview

Pauline Brice is affiliated with Hôpital Saint-Louis in France and has contributed extensively to medical research, particularly in the field of medicine. Their publications focus largely on pathology, oncology, and neurology, with additional work in pulmonary and respiratory medicine as well as dermatology.

Their research spans several main topics, including lymphoma diagnosis and treatment, central nervous system (CNS) lymphoma diagnosis and treatment, viral-associated cancers and disorders, cutaneous lymphoproliferative disorders research, lung cancer treatments and mutations, chronic lymphocytic leukemia research, and CAR-T cell therapy research.

Pauline Brice has published frequently in medical journals, with the most common venues being:

  • Blood
  • Haematologica
  • Hematological Oncology
  • Blood Advances
  • Leukemia & lymphoma / Leukemia and lymphoma

Frequent coauthors include:

  • Olivier Casasnovas
  • Hervé Ghesquières
  • Thomas Gastinne
  • Franck Morschhauser
  • Anne-Ségolène Cottereau

Selected recent papers authored by Pauline Brice include:

  • Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study, 2020, Haematologica
  • Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma, 2023, Blood
  • HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma, 2020, Blood
  • Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials, 2020, Cancer Medicine
  • Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up, 2023, Blood Advances

Best Publications

  • Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

    Gilles Salles;John Francis Seymour;Fritz Offner;Armando Lopez-Guillermo

  • Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

    Barbara Pro;Ranjana Advani;Pauline Brice;Nancy L. Bartlett

  • Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

    Robert Chen;Pier Luigi Zinzani;Michelle A. Fanale;Philippe Armand

  • Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte

    P Brice;Y Bastion;E Lepage;N Brousse

  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    Steven Horwitz;Owen A O'Connor;Barbara Pro;Tim Illidge

  • [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

    Corinne Haioun;Emmanuel Itti;Alain Rahmouni;Pauline Brice

  • Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

    Corinne Haioun;Eric Lepage;Christian Gisselbrecht;Gilles Salles

  • Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease

    Christophe Fermé;Houchingue Eghbali;Jacobus H. Meerwaldt;Chantal Rieux

  • Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

    Gilles Salles;Nicolas Mounier;Sophie de Guibert;Franck Morschhauser

  • Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma : Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

    Marc P. E. Andre;Theodore Girinsky;Massimo Federico;Oumedaly Reman

  • Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

    John M M Raemaekers;Marc P E André;Massimo Federico;Theodore Girinsky

  • ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

    Félix Reyes;Eric Lepage;Gérard Ganem;Thierry J. Molina

  • Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

    C. Haioun;E. Lepage;C. Gisselbrecht;Y. Bastion

  • Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma

    Philippe Solal-Celigny;Eric Lepage;Nicole Brousse;Felix Reyes

  • CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.

    Richard Delarue;Corinne Haioun;Vincent Ribrag;Pauline Brice

  • Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

    Franck Morschhauser;Nathan Fowler;Pierre Feugier;Reda Bouabdallah

  • A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma

    Andres Forero-Torres;John P. Leonard;Anas Younes;Joseph D. Rosenblatt

  • Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

    Catherine Sebban;Nicolas Mounier;Nicole Brousse;Coralie Belanger

  • Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

    Robert Chen;Pier Luigi Zinzani;Hun Ju Lee;Philippe Armand

  • Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

    Y Bastion;J Y Blay;M Divine;P Brice

Frequent Co-Authors

Christian Gisselbrecht
Christian Gisselbrecht Université Paris Cité
Martine Bagot
Martine Bagot Université Paris Cité
Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Corinne Haioun
Corinne Haioun Paris-Est Créteil University
Ali Guermazi
Ali Guermazi Boston University
Céleste Lebbé
Céleste Lebbé Hôpitaux Universitaires Paris-Ouest
Massimo Federico
Massimo Federico University of Modena and Reggio Emilia
Hervé Tilly
Hervé Tilly Grenoble Alpes University
Michel Henry-Amar
Michel Henry-Amar Université de Caen Normandie
John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine can open doors to a wide range of rewarding opportunities in healthcare, both at the bedside and beyond. For students who may prefer an alternate route to traditional medical school, several nursing schools that don't require teas or hesi exams make entering the nursing field more accessible. This is ideal for those seeking a faster pathway to a healthcare career.

If your interests lean toward healthcare leadership or management, consider the healthcare administration degrees available online. These programs prepare graduates for pivotal roles in hospitals, clinics, and healthcare organizations.

Registered nurses who are interested in advancing their credentials can look into asn to nurse practitioner programs. These bridge programs help nurses move from an associate degree to a master's degree, allowing for expanded clinical roles and higher earning potential.

Finally, for those passionate about nutrition and wellness, pursuing an online dietitian degree can lead to careers guiding individuals and communities toward healthier lifestyles. Each of these flexible online options aligns well with today’s diverse healthcare landscape and career aspirations.

Best Scientists Citing Pauline Brice

Trending Scientists

Recently Published Articles